biotactical
Biotactical B.V. is a Dutch life sciences company founded in 2023 that develops Rapid Microbial Methods for pharmaceutical quality control, reducing microbial detection time to 48-72 hours. The company targets pharma manufacturers and is preparing its first product launch in January 2026.
- Company typePrivate
- Founded2023
- HeadquartersOegstgeest, Netherlands
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
biotactical firmographics
Firmographics- Name
- biotactical
- Legal name
- Biotactical B.V.
- Website
- https://biotactical.nl
- Company type
- Private
- Founded year
- 2023
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Biotactical B.V. is a Dutch life sciences company founded in 2023 that develops Rapid Microbial Methods for pharmaceutical quality control, reducing microbial detection time to 48-72 hours. The company targets pharma manufacturers and is preparing its first product launch in January 2026.
- Ownership category
- akta.pro rank
biotactical industry classification
Industry- Product category
- Pharmaceutical Microbiology QC Testing
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Quality Control (QC) Testing Technologies for Biomanufacturing (release/stability assays, rapid microbiology) (HLAAAJAK)
- akta.pro secondary industry
- Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE)
Keywords
Where biotactical is headquartered
LocationHeadquarters
- HQ city
- Oegstgeest
- HQ country
- Netherlands
- HQ region
- Europe
Markets served
biotactical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
biotactical product offering
Product offeringCore offering
Biotactical B.V. develops Rapid Microbial Methods (RMM) for the pharmaceutical industry, providing alternative microbial detection solutions that compress conventional compendial testing timelines from approximately 5-7 days down to 48-72 hours. The offering targets quality control laboratories at pharmaceutical manufacturers and contract testing organizations that need faster sterility and bioburden results for batch release decisions.
Differentiator
Problem solved
Functional benefit
Products and services
- Rapid Microbial Methods (RMM) for pharmaceutical QC testing Rapid Microbial Methods offering for pharmaceutical manufacturers and contract testing organizations, providing alternative microbial detection solutions that compress conventional 5-7 day compendial testing timelines to 48-72 hours for sterility and bioburden QC release decisions.
Companies that use biotactical
Customer profileIdeal customer profiles1 record
biotactical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
biotactical partnerships and signals
Strategic signalScale indicators3 records
biotactical competitors and assessment
Company assessmentBroad incumbents
- bioMérieux: Global leader in in vitro diagnostics and industrial microbiology, offering comprehensive microbial detection, identification, and QC solutions to pharmaceutical manufacturers. Direct overlap with Biotactical's rapid microbial methods targeting the same pharma QC buyer.
- Thermo Fisher Scientific: Diversified life sciences giant with a substantial microbiology and QC testing portfolio serving pharmaceutical manufacturing customers. Listed alongside Biotactical in the pharma microbiology QC testing market study as a key player.
- FUJIFILM Wako Pure Chemical: Supplies microbiology testing reagents and QC products used in pharmaceutical manufacturing environments. Mentioned alongside Biotactical as a key player in the pharma microbiology QC testing market.
- Lonza Bioscience: Major biomanufacturing services and products provider offering endotoxin detection kits and QC testing solutions. Comparable as a pharma/biopharma QC vendor with overlapping customer base.
- Sartorius: Supplies bioprocess analytics and QC testing technologies to pharmaceutical and biopharmaceutical manufacturers. Comparable in addressing microbial and sterility testing needs within biomanufacturing QC workflows.
- Merck KGaA (MilliporeSigma): Life science products division offering microbiology testing consumables, instruments, and rapid detection solutions to pharmaceutical manufacturers. Comparable broad supplier into the same QC buyer.
Direct peers
- Charles River Laboratories: Provides endotoxin and microbial detection products (including rapid endotoxin systems) and QC testing services for pharma and biopharma manufacturers. Closely comparable to Biotactical's rapid microbial methods positioning.
- Rapid Micro Biosystems: Specialist in automated rapid microbial detection systems (Growth Direct) for pharmaceutical QC labs. Closest pure-play comparable to Biotactical in the rapid microbial methods niche for pharma manufacturing.
Regional players
- Eurofins Scientific: Global testing services network offering pharmaceutical microbiology, sterility, and bioburden testing services. Comparable as a service provider in pharma microbial testing, though primarily a lab-services model rather than product supplier.
Emerging players
- Solventum (formerly 3M Health Care): Supplies rapid diagnostic and detection platforms including ATP-based and rapid microbiology solutions used in healthcare and industrial QC settings. Overlaps with Biotactical on rapid microbial detection technology and adjacent customer base.
Market position
Customer concentration
biotactical social profiles
Digital presencebiotactical financial estimates
Financial estimateRevenue estimate
Valuation estimate
biotactical leadership team
Management profileNumber of profiles
Profiles1 record
biotactical funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
biotactical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about biotactical
What does biotactical do?
Biotactical B.V. develops Rapid Microbial Methods (RMM) for the pharmaceutical industry, providing alternative microbial detection solutions that compress conventional compendial testing timelines from approximately 5-7 days down to 48-72 hours. The offering targets quality control laboratories at pharmaceutical manufacturers and contract testing organizations that need faster sterility and bioburden results for batch release decisions.
Is biotactical a public or private company?
biotactical is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was biotactical founded?
biotactical was founded in 2023. It employs 1 to 10 people.
Where is biotactical based?
biotactical is headquartered in Oegstgeest, Netherlands, in the Europe region.
Who are biotactical's main competitors?
Broad incumbents on record are bioMérieux, Thermo Fisher Scientific, FUJIFILM Wako Pure Chemical, Lonza Bioscience, Sartorius and Merck KGaA (MilliporeSigma). Direct peers are Charles River Laboratories and Rapid Micro Biosystems. Eurofins Scientific is listed as a regional player. Solventum (formerly 3M Health Care) is listed as an emerging player.
Does biotactical have an API?
No public API is recorded for biotactical.
What industry is biotactical in?
biotactical's product category is Pharmaceutical Microbiology QC Testing. Its primary akta.pro industry code is HLAAAJAK, Quality Control (QC) Testing Technologies for Biomanufacturing (release/stability assays, rapid microbiology), with a secondary code of HLAGADAE, Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility). Its NAICS code is 541714 and its SIC code is 2835.